The Genomic Characteristics of ALK Fusion Positive Tumors in Chinese NSCLC Patients

Anaplastic lymphoma kinase (ALK) fusion events account for ~3–7% genetic alterations in patients with non-small cell lung cancer (NSCLC). In this study, we identified the ALK fusion patterns and a novel ALK fusion partner in 44 ALK positive NSCLC patients using a customized HapOncoCDx panel, and ide...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shaokun, Huang, Tanxiao, Liu, Ming, He, Wenlong, Zhao, YingShen, Yang, Lizhen, Long, Yingjiao, Zong, Dandan, Zeng, Huihui, Liu, Yuanyuan, Liao, Wenting, Duan, Jingxian, Gong, Subo, Chen, Shifu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225306/
https://www.ncbi.nlm.nih.gov/pubmed/32457845
http://dx.doi.org/10.3389/fonc.2020.00726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225306/
https://www.ncbi.nlm.nih.gov/pubmed/32457845
http://dx.doi.org/10.3389/fonc.2020.00726

Ejemplares similares